As of 2025-12-19, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 50.93 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -72.1%.
The range of the Relative Valuation is 46.36 - 57.06 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 18.0x | 17.0x |
| Forward P/E multiples | 17.9x - 22.0x | 19.1x |
| Fair Price | 46.36 - 57.06 | 50.93 |
| Upside | -74.6% - -68.7% | -72.1% |
| Date | P/E |